Status:
UNKNOWN
Investigation of Genomic Alteration in Patients With Luminal A or Luminal B Subtypes
Lead Sponsor:
Hellenic Cooperative Oncology Group
Conditions:
Breast Cancer
Eligibility:
FEMALE
18+ years
Brief Summary
This is a translational study in patients with operated early breast cancer of Luminal A or Luminal B sub types.The Hellenic Cooperative Oncology Group (HeCOG) has designed an observational biomarker-...
Detailed Description
The HE10A/13 study is an observational study of the Hellenic Cooperative Oncology Group (HeCOG). Its main purpose is the collection of biological material from patients in search of prognostic / predi...
Eligibility Criteria
Inclusion
- 18 years old or older
- Luminal A breast cancer sub type
- Luminal B breast cancer sub type
- Positive lymph nodes
- Node- negative with tumor stage or pathological features according to Saint Gallen guidelines.
Exclusion
- \-
Key Trial Info
Start Date :
April 24 2013
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
March 1 2023
Estimated Enrollment :
750 Patients enrolled
Trial Details
Trial ID
NCT04403984
Start Date
April 24 2013
End Date
March 1 2023
Last Update
March 8 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
George Fountzilas
Athens, Greece